Logos Global Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001792126

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2024 · 53 positions · Total reported value $1.03B · Top-10 concentration 56.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 72.7% · 25 new · 19 cut · 20 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +22.9% · vs SPY +8.1% · Prev Value $1.89B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2024 13F filing, Logos Global Management LP disclosed 53 equity positions with a combined reported value of $1.03B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 56.3% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2024 were XBI ($185.42M), IDYA ($59.69M), ARGX ($58.06M). By sector, the heaviest allocations are Health Care 68.9%, Other 31.1%. Versus the prior quarter, allocation shifted toward Other (+17.2pp) and away from Health Care (-17.2pp).

Versus the prior quarter, Logos Global Management LP opened 25 new positions, trimmed 19 and fully exited 20, a turnover rate of 72.7% of positions. The portfolio's overlap with the prior quarter was 51% of names.

The largest new positions opened in Q2 2024 were XBI ($185.42M), ARGX ($58.06M), MRUS ($50.29M).

Of the 20 positions fully exited versus the prior quarter, the largest were ALNY ($74.72M), IMCR ($58.50M), GERN ($29.70M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • XBI SPDR SERIES TRUST · $185.42M
  • ARGX ARGENX SE · $58.06M
  • MRUS MERUS N V · $50.29M
  • RVMD REVOLUTION MEDICINES INC · $46.57M
  • IRON DISC MEDICINE INC · $41.69M
  • MLTX MOONLAKE IMMUNOTHERAPEUTICS · $32.98M
  • NUVL NUVALENT INC · $14.79M
  • XENE XENON PHARMACEUTICALS INC · $14.62M

Fully Exited (vs previous quarter)

  • ALNY ALNYLAM PHARMACEUTICALS INC · prev qtr: $74.72M
  • IMCR IMMUNOCORE HLDGS PLC · prev qtr: $58.50M · history
  • GERN GERON CORP · prev qtr: $29.70M
  • CLDX CELLDEX THERAPEUTICS INC NEW · prev qtr: $27.28M · history
  • CGON CG ONCOLOGY INC · prev qtr: $13.17M · history
  • KYTX KYVERNA THERAPEUTICS INC · prev qtr: $12.42M
  • VRDN VIRIDIAN THERAPEUTICS INC · prev qtr: $12.26M
  • CGEM CULLINAN THERAPEUTICS INC · prev qtr: $11.93M

Insider Transactions (Form 4)

Latest Logos Global Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Logos Global Management LP is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q2 2026 it reported 68 US equity positions with a combined value of $2.32B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-117248 (status: Approved), registered 2019-08-26
  • Regulatory AUM (Form ADV): $2.25B as of 2026-04-22
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 5 private funds, of which 1 hedge funds

Portfolio Structure

  • 68 positions · $2.32B reported value (Q2 2026)
  • Top 10 holdings = 48.3% of reported value
  • Largest position: ERAS (ERASCA INC COM) at 9.6%
  • Average position size: $34.16M

Sector Tilt

  • Health Care 99.1%
  • Financials 0.1%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 25 new, 18 added, 19 reduced, 20 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 68.9%
Other 31.1%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 2.00M $185.42M 18.03%
18.03%
New
2 1.70M $59.69M 5.80%
5.80%
Add
3 135.00K $58.06M 5.65%
5.65%
New
4 850.00K $50.29M 4.89%
4.89%
New
5 1.20M $46.57M 4.53%
4.53%
New
6 925.00K $41.69M 4.05%
4.05%
New
7 5.15M $35.23M 3.43%
3.43%
Reduce
8 3.21M $34.72M 3.38%
3.38%
Reduce
9 950.00K $34.37M 3.34%
3.34%
Add
10 750.00K $32.98M 3.21%
3.21%
New
11 750.00K $31.42M 3.06%
3.06%
Add
12 1.50M $28.39M 2.76%
2.76%
Add
13 1.48M $28.05M 2.73%
2.73%
Hold
14 150.00K $23.70M 2.31%
2.31%
Reduce
15 800.00K $18.77M 1.82%
1.82%
Hold
16 450.00K $17.67M 1.72%
1.72%
Hold
17 5.03M $16.86M 1.64%
1.64%
Hold
18 400.00K $15.34M 1.49%
1.49%
Reduce
19 575.00K $15.18M 1.48%
1.48%
Reduce
20 195.00K $14.79M 1.44%
1.44%
New
21 375.00K $14.62M 1.42%
1.42%
New
22 300.00K $14.30M 1.39%
1.39%
New
23 1.05M $14.19M 1.38%
1.38%
New
24 5.90M $13.92M 1.35%
1.35%
New
25 595.00K $13.91M 1.35%
1.35%
Reduce
26 575.00K $13.52M 1.31%
1.31%
Add
27 1.20M $11.32M 1.10%
1.10%
Add
28 40.00M $10.84M 1.05%
1.05%
Hold
29 1.30M $10.43M 1.01%
1.01%
New
30 3.85M $10.39M 1.01%
1.01%
Add
31 265.00K $9.35M 0.91%
0.91%
Reduce
32 1.50M $9.30M 0.90%
0.90%
Add
33 250.00K $8.68M 0.84%
0.84%
New
34 1.30M $8.48M 0.82%
0.82%
New
35 2.80M $8.34M 0.81%
0.81%
Add
36 350.00K $7.54M 0.73%
0.73%
Reduce
37 1.50M $7.35M 0.71%
0.71%
Add
38 1.16M $7.00M 0.68%
0.68%
Add
39 539.08K $6.72M 0.65%
0.65%
New
40 4.70M $4.69M 0.46%
0.46%
Reduce
41 3.00M $4.68M 0.46%
0.46%
Reduce
42 500.00K $4.55M 0.44%
0.44%
Reduce
43 208.91K $4.37M 0.42%
0.42%
New
44 2.50M $3.98M 0.39%
0.39%
Add
45 300.00K $2.95M 0.29%
0.29%
Reduce
46 2.90M $2.90M 0.28%
0.28%
Hold
47 416.67K $2.86M 0.28%
0.28%
Reduce
48 600.00K $2.66M 0.26%
0.26%
Reduce
49 90.00K $2.43M 0.24%
0.24%
New
50 3.47M $1.74M 0.17%
0.17%
Hold

FAQ

What did Logos Global Management LP buy in 2024-Q2?

In its 2024-Q2 13F filing, Logos Global Management LP reported 53 equity positions worth $1.03B in aggregate; its largest disclosed positions were XBI ($185.42M), IDYA ($59.69M), ARGX ($58.06M).

How large is Logos Global Management LP's portfolio?

Logos Global Management LP reported $1.03B of long equity holdings across 53 positions as of 2024-Q2. Top-10 holdings account for 56.3% of reported value.

What is Logos Global Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/logos-global-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →